Table 6 Logistic regression analysis to assess the relationship between hospital mortality and demographic, epidemiological, clinical, and laboratory variables. (518)
Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | |
Female | 1.1 (0.7–1.7) | 0.61 | 1.1 (0.5–2.3) | 0.79 |
Age | 1.0 (1.0–1.0) | 0.01 | 1.0 (1.0–1.1) | 0.053 |
Septic shock | 4.4 (2.9–6.7) | < 0.0001 | 3.2 (1.5–7.0) | 0.003 |
Nursing home | 2.0 (1.1–3.8) | 0.03 | 0.4 (0.1–1.4) | 0.14 |
Antibiotic therapy in the past 90 days | 1.9 (1.2–3.2) | 0.01 | 1.1 (0.4–3.0) | 0.90 |
Hospitalization in the past 90 days | 2.2 (1.5–3.4) | < 0.0001 | 1.1 (0.4–2.7) | 0.85 |
Diabetes mellitus | 0.6 (0.4–1.0) | 0.04 | 0.8 (0.3–2.1) | 0.71 |
Peripheral vascular disease | 3.1 (1.4–6.6) | 0.004 | 1.4 (0.3–5.9) | 0.67 |
Severe immunosoppression | 1.8 (1.1–2.8) | 0.02 | 1.9 (0.8–4.9) | 0.17 |
Lung site | 1.5 (1.0–2.4) | 0.07 | 1.7 (0.7–4.0) | 0.21 |
Urinary tract site | 0.6 (0.4–0.9) | 0.01 | 0.6 (0.3–1.5) | 0.27 |
Skin and soft tissue site | 2.2 (1.1–4.7) | 0.03 | 3.2 (0.9–11.4) | 0.07 |
Renal failure | 1.5 (1.0–2.3) | 0.04 | 1.5 (0.7–3.1) | 0.26 |
Cognitive impairment | 1.6 (1.1–2.5) | 0.03 | 1.5 (0.7–3.0) | 0.30 |
Coagulation dysfunction | 2.0 (1.1–3.6) | 0.02 | 3.2 (1.1–8.8) | 0.03 |
SOFA | 1.3 (1.2–1.4) | < 0.0001 |  |  |
Quick SOFA | 1.5 (1.1–2.1) | 0.008 |  |  |
MDR pathogen isolated | 2.2 (1.4–3.6) | 0.001 | 4.6 (2.0–10.6) | < 0.001 |
Use of vasopressors | 2.4 (1.5–3.9) | < 0.0001 |  |  |
Polymicrobial infection | 2.6 (1.2–5.7) | 0.02 | 2.4 (0.7–7.7) | 0.15 |